Chimalakonda, A., Burke, J., Cheng, L., Catlett, I., Patel, A., Shen, J., Girgis, I., Banerjee, S. and Throup, J. (2020) “Selective Inhibition of Tyrosine Kinase 2 With Deucravacitinib (BMS-986165) Compared With Janus Kinase 1−3 Inhibitors”, SKIN The Journal of Cutaneous Medicine, 4(6), p. s108. doi: 10.25251/skin.4.supp.108.